Previous issue | Volume 89 | ESPE2018 | Next issue

57th Annual ESPE

Athens, Greece
27 Sep 2018 - 29 Sep 2018

Card image cap
ESPE 2018 57th European Society for Paediatric Endocrinology Annual Meeting 27-29 September 2018 Athens, Greece

Poster Presentations

Diabetes & Insulin P1

Poor Metabolic Control in Children and Adolescents with Type 1 Diabetes and Psychiatric Comorbidity
aDepartment of Pediatrics and Adolescent Medicine, Herlev Hospital, Herlev, Denmark; bSection of Biostatistics, University of Copenhagen, Copenhagen, Denmark; cNational Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark; dCenter of Adolescent Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark; eDepartment of Pediatrics and Adolescent Medicine, Nordsjællands Hospital, Hillerød, Denmark; fInstitute of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
hrp0089p1-p040
Concealment of Type 1 Diabetes in Adolescence Affects Adherence to Treatment, Metabolic Control, and Quality of Life
aSchneider Children’s Medical Center, Petah Tikva, Israel; bSackler Faculty of Medicine, Tel Aviv, Israel
hrp0089p1-p041
Risky Behaviors of Adolescents with Type 1 Diabetes in Comparison with their Healthy Peers
aNational and Kapodistrian University of Athens School of Medicine, Diabetes Unit, Second University Department of Pediatrics ‘P. & A. Kyriakou’ Children’s Hospital, Athens, Greece; bNational and Kapodistrian University of Athens School of Medicine, Adolescent Health Unit (A.H.U.) Second University Department of Pediatrics, ‘P. & A. Kyriakou’ Children’s Hospital, Athens, Greece
hrp0089p1-p042
The Effect of Social Burden on Paediatric Diabetes Outcomes
Evelina London Children’s Hospital, London, UK
hrp0089p1-p043
Parental Anxiety about Hypoglycemia of Children and Adolescents with Type 1 Diabetes Mellitus (T1DM) and the Associated Factors
aDiabetic Clinic, 2nd Department of Pediatrics, National and Kapodistrian University of Athens, ‘P.&A. Kyriakou’ Children’s Hospital, Athens, Greece; bNational School of Public Health, Athens, Greece; cDepartment of Statistical and Aspective Science, Athens, Greece
hrp0089p1-p044
Management of Diabetes During Ramadan Fasting in Children and Adolescents: Survey of Physicians' Perceptions and Practices in the Arab Society of Paediatric Endocrinology and Diabetes (ASPED) Countries
aPediatric Department, Diabetes Unit, Ain Shams University, Cairo, Egypt; bMafraq Hospital, Abu Dhabi, UAE; cNational Guard Hospital, Madinah, Saudi Arabia; dSheikh Khalifa Medical City, Abu Dhabi, UAE
hrp0089p1-p045
Phenotypes of Diabetes and Determinants of Glycemic Control and Diabetes Complications in Haitian Youth Living in Haiti
aMcGill University Health Center, Montreal, Canada; bUniversity of Massachusetts Medical School, Worcester, MA, USA; cKay Mackenson Clinic, Montrouis, Haiti
hrp0089p1-p046
Smoke Exposure and Cardio-metabolic Profile in Youth with Type 1 Diabetes
aPediatric Endocrinology Unit, University of Pavia and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; bDepartment of Public Health, Neurosciences, Experimental and Forensic Medicine, Laboratory of Dietetics and Clinical Nutrition University of Pavia, Pavia, Italy; cBiometry & Clinical Epidemiology, Scientific Direction, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
hrp0089p1-p047
Menstrual Cycle Disorders in Young Women with Type 1 Diabetes Mellitus
aDiabetes Center, Division of Endocrinology and Diabetes, First Department of Pediatrics, ‘Aghia Sophia’ Children’s Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece; bDepartment of Diabetes and Endocrinology, Hellenic Red Cross Hospital, Athens, Greece; cUnit of Reproductive Endocrinology, First Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece
hrp0089p1-p048
Life Changing Decisions due to Etiological Genetic Diagnosis in Families of Children with Maturity Onset Diabetes of the Young (MODY)
aPediatric Endocrine and Diabetes Unit, Edmond and Lili Safra Children’s Hospital, Sheba Medical Center, Ramat-Gan, Israel; bCNRS UMR 8199, Integrative Genomics and Modelling of Metabolic Diseases, University of Lille, European Genomics Institute of Diabetes, F-59000, Lille, France; cSackler school of Medicine Tel-Aviv University, Tel-Aviv, Israel; dGenomics of Common Disease, Imperial College London, London, UK
hrp0089p1-p049
NBAS Gene Mutation Causes Insulin-Dependent Diabetes Mellitus in a Patient with a Multisystem Disorder Consisting Immunodeficiency and Extremely Short Stature
aDivision of Pediatric Endocrinology and Diabetology, Center of Child and Adolescent Medicine, Justus Liebig University, Giessen, Germany; bHumangenetik, Goethe University, Frankfurt, Germany; cCentrum für Chronische Immundefizienz, Universitätsklinikum, Freiburg, Germany; dMax-Planck Institute for Molecular Genetics, Berlin, Germany
hrp0089p1-p050
Genetic Susceptibility to Type 1 Diabetes in Children: Analysis of Polymorphisms rs1990760 - IFIH1, rs20541 - IL13, rs231775 - CTLA 4
aDepartment of Pediatric Endocrinology, Diabetology with Cardiology Division, Medical University in Białystok, Bialystok, Poland; bDepartment of Endocrinology and Diabetes with Internal Medicine, Bialystok, Poland
hrp0089p1-p052
Neonatal Diabetes as a First Symptom of IPEX Syndrom
aMedical University of Gdansk, Gdansk, Poland; bMedical University of Lodz, Lodz, Poland
hrp0089p1-p053
CpG Methylation Status Changes within the Protein Tyrosine Phosphatase Non-Receptor Type 22 Gene Promoters in Children and Adolescents of Greek Origin with Type 1 Diabetes
a4th Department of Pediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Papageorgiou General Hospital, Thessaloniki, Greece; bLaboratory of Biological Chemistry, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece
hrp0089p1-p054
Wolfram Syndrome Case with Hypergonadotropic Hypogonadism: A Novel Mutation
aErciyes Univercity of Medicine, Pediatric Endocrinology Clinic, Kayseri, Turkey; bMemorial Hospital, Pediatric Endocrinologist, Kayseri, Turkey
hrp0089p1-p055
Different Clinical Findings in Maturity Onset Diabetes of the Young due to B-Lymphocyte Kinase Gene Mutations
aSaglik Bilimleri University, Zeynep Kamil Maternity and Children Hospital, Pediatric Endocrinology Clinic, İstanbul, Turkey; bSaglik Bilimleri University, Ankara Numune Hospital, Center of Genetic Diagnosis, Ankara, Turkey
hrp0089p1-p056
Three New Gene Variants (PTPRD, SYT9, and WFS1) Related to Korean MODY Children Decrease Insulin Secretion in Human Pancreatic Beta Cells
Department of Pediatrics, School of Medicine, Kyungpook Nat’l Univ, Kyungpook Nat’l Univ Hosp, Daegu, Republic of Korea
hrp0089p1-p057
Comprehensive Genetic Testing Shows One in Five Children with Diabetes and Non-Autoimmune Extra-Pancreatic Features Have Monogenic Aetiology
University of Exeter Medical School, Exeter, UK; bMolecular Genetics Department, Royal Devon and Exeter Hospital, Exeter, UK; cDiyarbakir Gazi Yasargil Eğitim ve Araştırma Hastanesi, Diyarbakır, Turkey; dKanuni Sultan Suleyman Training and Research Hospita, Istanbul, Turkey; eMarmara University Hospital, Istanbul, Turkey; fTepecik Training and Research Hospital, Izmir, Turkey; gDokuz Eylül University, Izmir, Turkey; hAnkara University School of Medicine, Ankara, Turkey; iSüleyman Demirel University, Isparta, Turkey; jKocaeil University Hospital, Izmit, Turkey; kIstinye University, Gaziosmanpasa Medical Park Hospital, Istanbul, Turkey; lHacettepe University Faculty of Medicine, Ankara, Turkey
hrp0089p1-p058
Impact of Diabetes During Pregnancy in Women Affected with GCK-MODY on Neonatal Health Outcome
aEvelina London Children’s Hospital, London, UK; bMedical University of Gdansk, Gdansk, Poland; cSpecilistic Hospital, Wejherowo, Poland
hrp0089p1-p059
IPEX as a Result of Mutations in FOXP3 Two Case Reports and Review of the Literature
aYinzhou People’s Hospital, Ningbo, China; bThe First Affiliated Hospital of Zhejiang University, Hangzhou, China.
hrp0089p1-p060
The Prevalence of Autonomic and Peripheral Neuropathy in Children and Adolescents with Type 1 Diabetic Mellitus (T1D) and Its Association with the Homozygous Status of Z-2/Z-2 Polymorphism of the Aldose Reductase Gene (AKR1B1) in the Polyol Pathway
aDiabetes Clinic, 2nd Department of Paediatrics, Medical School, University of Athens, ‘P&A Kyriakou’ Children’s Hospital, Athens, Greece; bDepartment of Medical Genetics, Choremeio Research Laboratory, Medical School, University of Athens, Athens, Greece; cDiabetes Center, Division of Endocrinology, Metabolism and Diabetes, First Department of Paediatrics, Medical School, University of Athens, ‘Aghia Sophia’ Children’s Hospital, Athens, Greece
hrp0089p1-p061
Establishment of Iron Overload Insulin Cell Model and the Effect Induced by Iron Overload on Oxidative Stress
Pediatric Department, Sun Yat-sen Memorial Hospital, Guangzhou, China
hrp0089p1-p062
Glucose Intolerance in Survivors of Childhood Hematologic Disorders
Department of Pediatrics, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea
hrp0089p1-p063
Efficacy of Mecasermin Treatment and Long-Term Survival in a Child with Leprechaunism
aUniversity Department Pro.Sa.M.I. ‘G. D’Alessandro’, University of Palermo, Italy, Palermo, Italy; bPediatric Hospital IRCCS ‘Bambino Gesù’, Rome, Italy; cUniversity of ‘Tor Vergata’, Rome, Italy; dNeonatal UTC, ARNAS Civico, Palermo, Palermo, Italy
hrp0089p1-p064
Evaluation of Diabetes Related Complications and Endothelial Dysfunction in Adolescents with Type 1 Diabetes
aThe Department of Paediatric Endocrinology and Diabetes, National Children’s Hospital, Tallaght University Hospital, Dublin, Ireland; bTrinity College Dublin, The University of Dublin, Dublin, Ireland; cUniversity of Limerick GEMS, Limerick, Ireland
hrp0089p1-p065
Insulin Resistance Parameters in Children Who Were Born Very Preterm and Adequate for Gestational Age
aEndocrinology Unit, Division of Pediatrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile; bEndocrinology Unit, Division of Pediatrics, Faculty of Medicine, Pontifica Universidad Católica de Chile, Santiago, Chile; cServicio de Pediatría, Hospital Higueras, Talcahuano, Chile; dNephrology Unit, Division of Pediatrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile; eDivision of Pediatrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile; eComplejo Asistencial Sótero del Río, Santiago, Chile; fRed de Salud UC-Christus, Santiago, Chile; gEndocrinology Department, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile; hDepartment of Clinical Laboratories, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
hrp0089p1-p067
Impact on Final Height of Functional Insulin-Therapy in Type 1 Diabetes Mellitus Pediatric Patients - Experience from a Portuguese Pediatric Endocrinology Unit
aCoimbra Pediatric Hospital – Universitary and Hospital Central of Coimbra, Coimbra, Portugal; bPediatric Service, Vila Real Hospital, Vila Real, Portugal; cEndocrinology, Coimbra Pediatric Hospital – Universitary and Hospital Central of Coimbra, Coimbra, Portugal; dPediatric Service, Leiria Hospital, Leiria, Portugal
hrp0089p1-p068
Triglyceride Glucose Index as a Predictor of Impaired Glucose Tolerance in Overweight and Obese Adolescents
aPhramongkutklao Hospital and College of Medicine, Bangkok, Thailand; bVejthani Hospital, Bangkok, Thailand
hrp0089p1-p069
Birth Weight in Offsprings of Mothers with Gestational Diabetes Mellitus due to Mutations in GCK Gene
aEndocrinology Research Centre, Moscow, Russian Federation; bMoscow Regional Research Institute of Obstetrics and Gynecology, Moscow, Russian Federation.
hrp0089p1-p070
Increasing Use of Continuous Glucose Monitoring (CGM) Among Youth with Type 1 Diabetes (T1D): Icomparison of Youth from the T1D Exchange (T1DX) and the DPV Initiative
aJaeb Center for Health Rresearch, Tampa, USA; bUniversity of Ulm, ZIBMT, Institute of Epidemiology and Medical Biometry; German Center for Diabetes Research, Ulm, Germany; cGerman Center for Diabetes Research (DZD), Munchen-Neuherberg, Germany; dStanford University School of Medinice, Stanford, USA; eMedical University of Innsbruck, Department of Pediatrics, Innsbruck, Austria
hrp0089p1-p072
Catheter Site Selection and Anthropometric Measurements at Subjects with Type 1 Diabetes and Continuous Subcutaneous Insulin Infusion
aDiabetes Centre, A’ Department of Pediatrics, P&A Kyriakou Children’s Hospital, Athens, Greece; bRadiology Department, P&A Kyriakou Children’s Hospital, Athens, Greece; cDiabetes Center, 1st Pediatric Department of ‘Panagiotis & Aglaia Kiriakou’ Children’s Hospital, Athens, Greece
hrp0089p1-p074
Open Source Artificial Pancreas Systems Used from Bulgarian Children and Young People with Diabetes
aBulgarian National Society for Pediatric Endocrinology, Sofia, Bulgaria; bCreator of AndroidAPS, Prague, Czech Republic; cAssociate of the Association ‘Kulture without Borders’, Sofia, Bulgaria; dPresident of the Association ‘Kulture without Borders’, Sofia, Bulgaria; eAssociate of the Association ‘Kulture without borders’, Varna, Bulgaria; fLocal Insurance Company, Dobrich, Bulgaria; gAssociate of the Association ‘Kulture without borders’, Sofia, Bulgaria
hrp0089p1-p075
National Survey of Usage of Continuous Glucose Monitoring in Children and Adolescents at Non Reimbursed Setting
aUMHAT ‘St. Marina’, Varna, Bulgaria; bMedical University, Varna, Bulgaria; cUMHAT, Pleven, Bulgaria; dMedical University, Pleven, Bulgaria; eSHAT of Children’s Diseases, Sofia, Bulgaria; fTokuda Hospital, Sofia, Bulgaria; gOutpatient Clinic of Diabetology, Stara Zagora, Bulgaria; hOutpatient Clinic of Diabetology, Dobrich, Bulgaria; iUMHAT ‘St.George’, Plovdiv, Bulgaria; jMedical University, Plovdiv, Bulgaria; kOutpatient Clinic of Diabetology, Burgas, Bulgaria
hrp0089p1-p076
Additional Insulin is Necessary to Prevent Rise in Blood Glucose after Fat-protein-rich Meals in Type 1 Diabetes
aPediatric Endocrinology and Diabetology, Tübingen, Germany; bPediatric Diabetology, Tübingen, Germany; cChildren’s Hospital, Reutlingen, Germany
hrp0089p1-p077
A Novel SLCA16A1 Mutation in an Infant with Hypoglycemia and Severe Metabolic Ketoacidosis
Department of Pediatric Medicine, Division of Endocrinology, Sidra Medicine, Doha, Qatar
hrp0089p1-p079
Successful Transition to Sulfonylurea Therapy in Infant with Neonatal Diabetes, Developmental Delay, Epilepsy (DEND Syndrome) due to F132L ABCC8 Mutation
aNational Endocrinology Research Centre, Moscow, Russian Federation; bMorozovskaya Children City Clinical Hospital of the Moscow Healthcare Department, Moscow, Russian Federation
hrp0089p1-p080
ZFP57-associated Transient Neonatal Diabetes is Responsive to Oral Sulfonylurea Treatment
aDepartment of General Pediatrics, Neonatology and Pediatric Cardiology, University Children’s Hospital, Duesseldorf, Germany; bCenter for Human Genetics, Bioscientia, Ingelheim, Germany; cDepartment of Pediatrics, Solingen Municipal Hospital, Solingen, Germany; dPediatric Practice Ufergarten, Solingen, Germany
hrp0089p1-p081
HERV-W-Env Protein Expression in Pediatric Type 1 Diabetes Patients
aDepartment of Pediatric Endocrinology and Diabetology, CHUV, Lausanne, Switzerland; bGeneuro Innovation, Lyon, France
hrp0089p1-p083
T- and B-Lymphocytes Levels in Children with Type 1 Diabetes in Association with Candida Infection
aDepartment of Pediatrics, Medical University of Pleven, Pleven, Bulgaria; bDepartment of Clinical Laboratory, Immunology and Allergology, Medical University of Pleven, Pleven, Bulgaria
hrp0089p1-p085
Investigation into [beta]-cell Adaptation During Puberty
Centre de recherche du diabète de Montréal, CR-CHUM, Montreal, Canada
hrp0089p1-p087
Features of T2DM in Adolescents with Low Titer of ICA and IAA
Endocrinology Research Center, Moscow, Russian Federation
hrp0089p1-p089
Increasing Trend of Fasting Plasma Glucose Levels and Impaired Fasting Glucose in Non-Diabetic Korean Youth and Young Adults: A Nationally Representative Population-Based Study
aDepartment of Pediatrics, Inje University Ilsan Paik Hospital, Goyang, Republic of Korea; bDepartment of Pediatrics, Seoul National University Children’s Hospital, Seoul, Republic of Korea; cDepartment of Pediatrics, Seoul National University Bundang Hospital, Seongnam, Republic of Korea; cDepartment of Pediatrics, Seoul Metropolitan Government-Seoul National Univertisy Boramae Medical Center, Seoul, Republic of Korea
hrp0089p1-p090
Screening for T2D in High Risk Egyptian Children and Adolescents Using Strip HbA1c and OGTT
aCairo University, Cairo, Egypt; bEl Galaa Hospital, Cairo, Egypt
hrp0089p1-p091